Complex arrhythmias in pregnant women
Tashkent Medical Academy, Tashkent, Uzbekistan.
Research Article
Magna Scientia Advanced Research and Reviews, 2023, 08(01), 065–067
Article DOI: 10.30574/msarr.2023.8.1.0070
Publication history:
Received on 18 April 2023; revised on 24 May 2023; accepted on 27 May 2023
Abstract:
Actuality: NT-B-type natriuretic peptide (BNP) has been recognized as a powerful cardiovascular biomarker for a number of disease states, specifically heart failure.
Objective: To analyze the specifics of clinical course of pregnancy in women with cardiac diseases.
Material and methods: The level of N-terminal brain natriuretic peptide (NT-proBNP) was measured by electrochemiluminiscent analyzer Cobas e411 (Roche, Swiss) at 34±6 week of pregnancy.
Results: Level of NTproBNP was higher than 125 pg/mL in 12 patients (21,4%) and its mean value was 330,3±54,7 pg/mL; in women with increased NT-proBNP complications in cardiovascular system developed 3 times more often.
Conclusion: NT-proBNP have established guideline-recommended roles in the diagnosis and prognosis of patients with suspected or known heart failure.
Keywords:
Arrythmias; Pregnancy; Brain natriuretic peptide; Cardiovascular disease
Full text article in PDF:
Copyright information:
Copyright © 2023 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0